Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Epirubicin Targets B56δ to Limit Kidney Fibrosis
2026-08-24
The reference study identifies epirubicin as a small-molecule inhibitor of the PP2A regulatory subunit B56δ and links this intervention to reduced lipid accumulation and fibrosis in obstructive kidney disease models. Its main contribution is to shift therapeutic attention from the broadly active PP2A catalytic subunit toward a more selective regulatory component, while the findings remain preclinical and require additional mechanistic and safety validation.
-
Acridine Orange hydrochloride: Practical Staining Guide
2026-08-23
Acridine Orange hydrochloride provides membrane-permeable, dual-channel nucleic acid staining for workflows that need context-dependent green and red fluorescence, including cell cycle analysis, apoptosis detection, and flow cytometry. It should be method-validated for each cell model and is not a substitute for sequence-specific nucleic acid assays, standalone apoptosis diagnosis, or long-term storage of prepared solutions.
-
Doxycycline in AAA Research: Workflow & Optimization
2026-08-22
Doxycycline combines tetracycline antibiotic activity with metalloproteinase inhibition, making it useful for mechanistic studies of vascular remodeling, cancer-cell proliferation, and antimicrobial responses. This guide translates a targeted AAA nanomedicine study into practical assay designs, dosing controls, and troubleshooting decisions for free-drug experiments and delivery-platform comparisons.
-
Deferoxamine Mesylate in Lysosomal Stress
2026-08-22
Deferoxamine mesylate is an iron-chelating agent that can help dissect how iron availability intersects with lysosomal stress during glucose starvation. This article translates the TCF25–V-ATPase–ferritinophagy findings of a 2025 Cell Reports study into practical assay decisions while defining the compound’s limits.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-21
Use a fluorescein-conjugated secondary antibody to convert rabbit-primary immunoassays into sensitive, imageable readouts for HMGB1 validation. This practical workflow covers immunofluorescence, flow cytometry, tissue imaging, storage, controls, and troubleshooting for diabetic nephropathy research.
-
Aconitase Activity Colorimetric Assay Kit Workflow
2026-08-20
Turn aconitase activity into a practical readout for oxidative damage, mitochondrial dysfunction, and immunometabolic studies. This workflow combines 450 nm colorimetry, disciplined sample handling, and orthogonal validation to distinguish altered enzyme function from changes in protein abundance.
-
Coronavirus Macrodomain–PARP Antiviral Defense
2026-08-20
The reference study shows that coronavirus macrodomains counter a host antiviral pathway driven by PARP12 and PARP14. By combining macrodomain-mutant viruses, pharmacological inhibition, gene knockdown, and macrophage and animal models, the authors connect ADP-ribosylation with both viral restriction and interferon regulation.
-
CD28–ARS2 Rewires PKM Splicing in CD8+ T Cells
2026-08-19
The reference study identifies a CD28–ARS2 signaling axis that alters alternative splicing of PKM, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings connect costimulatory signaling to RNA processing, glucose utilization, interferon-γ production, and antitumor activity while revealing a mechanism that operates independently of the canonical CD28–PI3K pathway.
-
Sisomicin Activity Against Clinical Isolates
2026-08-19
Stewart and Bodey evaluated sisomicin against 565 clinical isolates and showed activity broadly comparable to gentamicin and tobramycin, with greater potency than kanamycin and butirosin against tested gram-negative bacilli. The study also identified an important cross-resistance pattern: isolates resistant to gentamicin and tobramycin were generally resistant to sisomicin, whereas many remained susceptible to amikacin.
-
Phosbind Biotin LC Western Blot Guide
2026-08-18
Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes without relying on a sequence-specific phospho-antibody. It is intended for membrane-based Western Blot workflows with streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of working solutions.
-
Clasto-Lactacystin β-lactone in Proteasome Assays
2026-08-18
Clasto-Lactacystin β-lactone enables controlled, cell-based interrogation of proteasome-dependent protein turnover, from pulse-chase experiments to viral inflammation models. This workflow-oriented guide shows how to connect proteasome inhibition assay data with RIPK3 degradation, necroptosis, cancer research, and disease-model readouts while avoiding common interpretation errors.
-
MLN4924: NEDD8 Pathway Workflow
2026-08-17
MLN4924 enables controlled inhibition of the NEDD8-activating enzyme to connect pathway biochemistry with cell-cycle, apoptosis, and protein-degradation phenotypes. This practical guide distinguishes broad NAE blockade from downstream UBE2F–CRL5 targeting and provides assay-ready optimization and troubleshooting strategies.
-
ITGA3/FAK/YAP Dysfunction in COPD Alveoli
2026-08-17
The reference study identifies loss of ITGA3 and dysregulation of the FAK/YAP pathway as a mechanistic link between cigarette smoke-associated oxidative stress and impaired alveolar type II cell regeneration in COPD. By combining patient material, a chronic smoke-exposure model, and alveolar organoids, the work positions ITGA3 as a potential target for restoring AT2 cell stemness, while also defining important limits for translating pathway-modulating tools into pulmonary research.
-
Aconitase Activity Colorimetric Assay Kit Guide
2026-08-16
The Aconitase Activity Colorimetric Assay Kit provides a practical readout of TCA-cycle integrity that complements studies of CD8+ T-cell metabolic flexibility. This guide explains how K2226 distinguishes glycolytic adaptation from mitochondrial iron-sulfur damage and supports oxidative damage measurement.
-
Aconitase Activity Colorimetric Assay Kit
2026-08-15
A practical, scenario-driven guide to using Aconitase Activity Colorimetric Assay Kit SKU K2226 for TCA-cycle, oxidative-stress, and immunometabolic studies. It explains assay principles, controls, protocol decisions, interpretation, and vendor-selection criteria without overstating unsupported performance claims.